Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 19, 2023 - Issue 12
Submit an article Journal homepage
265
Views
0
CrossRef citations to date
0
Altmetric
Review

Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in COVID-19 patients: a narrative review

Tsubasa Takizawaa Department of Neurology, Keio University School of Medicine, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2605-7200View further author information
ORCID Icon,
Keiko Iharaa Department of Neurology, Keio University School of Medicine, Tokyo, Japan;b Japanese Red Cross Ashikaga Hospital, Ashikaga, JapanView further author information
,
Shunsuke Unoc Department of Infectious Diseases, Keio University School of Medicine, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-9223-6138View further author information
ORCID Icon,
Seiya Ohtania Department of Neurology, Keio University School of Medicine, Tokyo, Japan;d Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, JapanView further author information
,
Narumi Watanabea Department of Neurology, Keio University School of Medicine, Tokyo, JapanView further author information
,
Noboru Imaie Department of Neurology, Japanese Red Cross Shizuoka Hospital, Shizuoka, JapanView further author information
,
Jin Nakaharaa Department of Neurology, Keio University School of Medicine, Tokyo, JapanView further author information
,
Satoko Horid Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-4596-5418View further author information
ORCID Icon,
David Garcia-Azorinf Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, SpainORCID Iconhttps://orcid.org/0000-0002-3132-1064View further author information
ORCID Icon &
Paolo Martellettig School of Health Sciences, Unitelma Sapienza University of Rome, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-6556-4128View further author information
ORCID Icon show all
Pages 951-967 | Received 13 May 2023, Accepted 02 Nov 2023, Published online: 15 Nov 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.